Evangelos Kiskinis

9.2k citations

54 papers · 5.1k indexed · 5 hit papers · h-index 28

Molecular Biology top 2%
Neurology top 1%
Cellular and Molecular Neuroscience top 2%
Physiology top 2%
Genetics top 1%

Co-authors: Kevin Eggan Alexander Meissner Gabriella L. Boulting Christoph Bock Malcolm G. Parker Derek H. Oakley Mackenzie W. Amoroso Gist F. Croft
Topics: Amyotrophic Lateral Sclerosis Research (12 papers)CRISPR and Genetic Engineering (11 papers)Pluripotent Stem Cells Research (11 papers)
Cited by: Neurology Genetics Molecular Biology
Journals: Science Cell Journal of Biological Chemistry
Partner nations: United States United Kingdom Germany

In The Last Decade

Evangelos Kiskinis

53 papers receiving 5.0k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Reference Maps of Human ES and iPS Cell Variation Enable High-Throughput Characterization of Pluripotent Cell Lines

2011 713 citations Evangelos Kiskinis, Hongcang Gu et al. profile →
Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson’s disease

2017 625 citations Lena F. Burbulla, Pingping Song et al. Science profile →
Axonal Transport of TDP-43 mRNA Granules Is Impaired by ALS-Causing Mutations

2014 497 citations Luis A. Williams, Evangelos Kiskinis et al. Neuron profile →
Intrinsic Membrane Hyperexcitability of Amyotrophic Lateral Sclerosis Patient-Derived Motor Neurons

2014 481 citations Brian J. Wainger, Evangelos Kiskinis et al. profile →
Bioactive scaffolds with enhanced supramolecular motion promote recovery from spinal cord injury

2021 276 citations Ivan R. Sasselli, J. Alberto Ortega et al. Science profile →

Peers

Countries citing papers authored by Evangelos Kiskinis

Since Specialization

Citations

This map shows the geographic impact of Evangelos Kiskinis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evangelos Kiskinis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evangelos Kiskinis more than expected).

Fields of papers citing papers by Evangelos Kiskinis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evangelos Kiskinis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evangelos Kiskinis. The network helps show where Evangelos Kiskinis may publish in the future.

Co-authorship network of co-authors of Evangelos Kiskinis

This figure shows the co-authorship network connecting the top 25 collaborators of Evangelos Kiskinis. A scholar is included among the top collaborators of Evangelos Kiskinis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evangelos Kiskinis. Evangelos Kiskinis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Need for Speed; Investigating Channelopathy-Associated Epilepsy Using High Throughput Electrophysiological Approaches 2024 ·Epiliepsy currents ·Alfred L. George,Evangelos Kiskinis	1
2	SeqVerify: An accessible analysis tool for cell line genomic integrity, contamination, and gene editing outcomes 2024 ·Stem Cell Reports ·Merrick Pierson Smela,(unknown),Steven Lubbe,Evangelos Kiskinis,George M. Church	1
3	Loss of function of the ALS-associated NEK1 kinase disrupts microtubule homeostasis and nuclear import 2023 ·Science Advances ·Jacob R. Mann,(unknown),(unknown),(unknown),Francesco Alessandrini,Eric N. Anderson,R.M. Mayers,(unknown),(unknown),(unknown),Desiree M. Baron,(unknown),John E. Landers,Udai Bhan Pandey,Evangelos Kiskinis	18
4	CLIP-Seq analysis enables the design of protective ribosomal RNA bait oligonucleotides against C9ORF72 ALS/FTD poly-GR pathophysiology 2023 ·Science Advances ·J. Alberto Ortega,Ivan R. Sasselli,Marco Boccitto,(unknown),(unknown),Yichen Li,Kohei Sato,Tristan D. Clemons,(unknown),(unknown),Eric N. Anderson,Jesús Asín,Justin K. Ichida,Udai Bhan Pandey,Sandra L. Wolin,Samuel I. Stupp,Evangelos Kiskinis	5
5	Polyurethane Culture Substrates Enable Long-Term Neuron Monoculture in a Human in vitro Model of Neurotrauma 2023 ·SHILAP Revista de lepidopterología ·(unknown),(unknown),Éric Martin,(unknown),(unknown),Simon Dixon,(unknown),Zhangli Peng,Evangelos Kiskinis,John D. Finan	1
6	NUP62 localizes to ALS/FTLD pathological assemblies and contributes to TDP-43 insolubility 2022 ·Nature Communications ·Amanda M. Gleixner,(unknown),(unknown),Eric N. Anderson,Nandini Ramesh,(unknown),Jenna R. Gale,Jocelyn C. Mauna,Jacob R. Mann,Katie E. Copley,Elizabeth L. Daley,J. Alberto Ortega,M.E. Cicardi,Evangelos Kiskinis,Julia Kofler,Udai Bhan Pandey,Davide Trotti,Christopher J. Donnelly	35
7	Homozygous might be hemizygous: CRISPR/Cas9 editing in iPSCs results in detrimental on-target defects that escape standard quality controls 2022 ·Stem Cell Reports ·Dina Simkin,(unknown),Bernabé I. Bustos,Christina M. Ambrosi,Steven J. Ryan,Valeriya Baru,Luis A. Williams,Graham T. Dempsey,Owen B. McManus,John E. Landers,Steven Lubbe,Alfred L. George,Evangelos Kiskinis	36
8	‘Channeling’ therapeutic discovery for epileptic encephalopathy through iPSC technologies 2022 ·Trends in Pharmacological Sciences ·Dina Simkin,Christina M. Ambrosi,(unknown),Luis A. Williams,(unknown),(unknown),Graham T. Dempsey,Alfred L. George,Owen B. McManus,Evangelos Kiskinis	14
9	A C. elegans model of C9orf72-associated ALS/FTD uncovers a conserved role for eIF2D in RAN translation 2021 ·Nature Communications ·Yoshifumi Sonobe,(unknown),Gopinath Krishnan,(unknown),Ghanashyam D. Ghadge,(unknown),(unknown),Yuanzheng Gu,Mark W. Kankel,André EX Brown,Evangelos Kiskinis,Tania F. Gendron,Fen‐Biao Gao,Raymond P. Roos,Paschalis Kratsios	36
10	Dyshomeostatic modulation of Ca2+-activated K+ channels in a human neuronal model of KCNQ2 encephalopathy 2021 ·eLife ·Dina Simkin,(unknown),Carlos G. Vanoye,Reshma R. Desai,Bernabé I. Bustos,(unknown),J. Alberto Ortega,Marc P. Forrest,(unknown),Peter Penzes,Linda Laux,Steven Lubbe,J Gordon Millichap,Alfred L. George,Evangelos Kiskinis	26
11	TETs compete with DNMT3 activity in pluripotent cells at thousands of methylated somatic enhancers 2020 ·Nature Genetics ·Jocelyn Charlton,(unknown),Alexandra L. Mattei,(unknown),Jing Liao,Éric Martin,Pay Gießelmann,Björn Brändl,Elena K. Stamenova,Frank Müller,Evangelos Kiskinis,Andreas Gnirke,Zachary D. Smith,Alexander Meissner	82
12	RNA dependent suppression of C9orf72 ALS/FTD associated neurodegeneration by Matrin-3 2020 ·Acta Neuropathologica Communications ·Nandini Ramesh,Elizabeth L. Daley,Amanda M. Gleixner,Jacob R. Mann,Sukhleen Kour,(unknown),Eric N. Anderson,Julia Kofler,Christopher J. Donnelly,Evangelos Kiskinis,Udai Bhan Pandey	22
13	Nucleocytoplasmic Proteomic Analysis Uncovers eRF1 and Nonsense-Mediated Decay as Modifiers of ALS/FTD C9orf72 Toxicity 2020 ·Neuron ·J. Alberto Ortega,Elizabeth L. Daley,Sukhleen Kour,(unknown),(unknown),(unknown),Elizabeth Hall,(unknown),(unknown),Tania F. Gendron,Christopher J. Donnelly,Teepu Siddique,Jeffrey N. Savas,Udai Bhan Pandey,Evangelos Kiskinis	54
14	Dissecting the Functional Consequences of De Novo DNA Methylation Dynamics in Human Motor Neuron Differentiation and Physiology 2018 ·Cell stem cell ·Michael J. Ziller,J. Alberto Ortega,Katharina A. Quinlan,David P. Santos,Hongcang Gu,Éric Martin,Christina Galonska,Ramona Pop,(unknown),Alba Di Pardo,Mei Huang,Herbert Y. Meltzer,Andreas Gnirke,C. J. Heckman,Alexander Meissner,Evangelos Kiskinis	52
15	Direct evidence of impaired neuronal Na/K-ATPase pump function in alternating hemiplegia of childhood 2018 ·Neurobiology of Disease ·(unknown),Christopher H. Thompson,(unknown),(unknown),Kathryn J. Swoboda,Evangelos Kiskinis,Kevin C. Ess,Alfred L. George	20
16	Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson’s diseasebreakdown → 2017 ·Science ·Lena F. Burbulla,Pingping Song,Joseph R. Mazzulli,Enrico Zampese,Yvette C. Wong,Sohee Jeon,David P. Santos,Judith Blanz,Carolin D. Obermaier,(unknown),Jeffrey N. Savas,Evangelos Kiskinis,Xiaoxi Zhuang,Rejko Krüger,D. James Surmeier,Dimitri Krainc	625
17	A functionally characterized test set of human induced pluripotent stem cells 2011 ·Nature Biotechnology ·Gabriella L. Boulting,Evangelos Kiskinis,Gist F. Croft,Mackenzie W. Amoroso,Derek H. Oakley,Brian J. Wainger,Damian J. Williams,David J. Kahler,Mariko Yamaki,Lance S. Davidow,(unknown),John T. Dimos,(unknown),Amy B. MacDermott,Clifford J. Woolf,Christopher E. Henderson,Hynek Wichterle,Kevin Eggan	364
18	RIP140-Targeted Repression of Gene Expression in Adipocytes 2005 ·Molecular and Cellular Biology ·Mark Christian,Evangelos Kiskinis,(unknown),Göran Leonardsson,Roger White,Malcolm G. Parker	156
19	Use of the alkaline comet assay for industrial genotoxicity screening 2001 ·Food and Chemical Toxicology ·Andreas Hartmann,Azeddine Elhajouji,Evangelos Kiskinis,(unknown),(unknown),(unknown),Wilfried Frieauff,Willi Suter	84
20	Influence of cytotoxicity and compound precipitation on test results in the alkaline comet assay 2001 ·Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·Andreas Hartmann,Evangelos Kiskinis,(unknown),Willi Suter	50

About Evangelos Kiskinis

Evangelos Kiskinis is a scholar working on Aging, Neurology and Developmental Neuroscience, having authored 54 papers that have together received 5.1k indexed citations. Recurring topics across this work include Amyotrophic Lateral Sclerosis Research (12 papers), CRISPR and Genetic Engineering (11 papers) and Pluripotent Stem Cells Research (11 papers). The work is most often cited by research in Neurology (1.2k citations), Genetics (650 citations) and Molecular Biology (3.4k citations). Evangelos Kiskinis has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Kevin Eggan, Alexander Meissner, Gabriella L. Boulting, Christoph Bock, Malcolm G. Parker, Derek H. Oakley, Mackenzie W. Amoroso, Gist F. Croft, Andreas Gnirke and Zachary D. Smith. Their work appears in journals such as Science, Cell and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact